Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Characterization of bound water in skin hydrators prepared with and without a 3D3P interpenetrating polymer network.

Majewski GP, Rodan K, Fields K, Falla TJ.

Skin Res Technol. 2019 Mar;25(2):150-157. doi: 10.1111/srt.12624. Epub 2018 Aug 16.

PMID:
30112768
2.
3.

Efficacy of a twice-daily, 3-step, over-the-counter skincare regimen for the treatment of acne vulgaris.

Rodan K, Fields K, Falla TJ.

Clin Cosmet Investig Dermatol. 2017 Jan 4;10:3-9. doi: 10.2147/CCID.S125438. eCollection 2017.

4.

Efficacy of hexapeptide-7 on menopausal skin.

Falla TJ, Zhang L.

J Drugs Dermatol. 2010 Jan;9(1):49-54.

PMID:
20120425
5.

Potential therapeutic application of host defense peptides.

Zhang L, Falla TJ.

Methods Mol Biol. 2010;618:303-27. doi: 10.1007/978-1-60761-594-1_19.

PMID:
20094872
6.

Cosmeceuticals and peptides.

Zhang L, Falla TJ.

Clin Dermatol. 2009 Sep-Oct;27(5):485-94. doi: 10.1016/j.clindermatol.2009.05.013. Review.

PMID:
19695481
7.

Bioactive peptides: signaling the future.

Fields K, Falla TJ, Rodan K, Bush L.

J Cosmet Dermatol. 2009 Mar;8(1):8-13. doi: 10.1111/j.1473-2165.2009.00416.x. Review.

PMID:
19250159
8.

Host defense peptides for use as potential therapeutics.

Zhang L, Falla TJ.

Curr Opin Investig Drugs. 2009 Feb;10(2):164-71. Review.

PMID:
19197794
9.

Antimicrobial peptides: therapeutic potential.

Zhang L, Falla TJ.

Expert Opin Pharmacother. 2006 Apr;7(6):653-63. Review.

PMID:
16556083
10.

Antimicrobial peptide therapeutics for cystic fibrosis.

Zhang L, Parente J, Harris SM, Woods DE, Hancock RE, Falla TJ.

Antimicrob Agents Chemother. 2005 Jul;49(7):2921-7.

11.

HB-107, a nonbacteriostatic fragment of the antimicrobial peptide cecropin B, accelerates murine wound repair.

Lee PH, Rudisill JA, Lin KH, Zhang L, Harris SM, Falla TJ, Gallo RL.

Wound Repair Regen. 2004 May-Jun;12(3):351-8.

PMID:
15225214
12.

Cationic antimicrobial peptides - an update.

Zhang L, Falla TJ.

Expert Opin Investig Drugs. 2004 Feb;13(2):97-106. Review.

PMID:
14996645
13.

Identification of Proteus mirabilis mutants with increased sensitivity to antimicrobial peptides.

McCoy AJ, Liu H, Falla TJ, Gunn JS.

Antimicrob Agents Chemother. 2001 Jul;45(7):2030-7.

14.

Development of protegrins for the treatment and prevention of oral mucositis: structure-activity relationships of synthetic protegrin analogues.

Chen J, Falla TJ, Liu H, Hurst MA, Fujii CA, Mosca DA, Embree JR, Loury DJ, Radel PA, Cheng Chang C, Gu L, Fiddes JC.

Biopolymers. 2000;55(1):88-98.

PMID:
10931444
15.

IB-367, a protegrin peptide with in vitro and in vivo activities against the microflora associated with oral mucositis.

Mosca DA, Hurst MA, So W, Viajar BS, Fujii CA, Falla TJ.

Antimicrob Agents Chemother. 2000 Jul;44(7):1803-8.

16.

Dynamics of meningococcal long-term carriage among university students and their implications for mass vaccination.

Ala'Aldeen DA, Neal KR, Ait-Tahar K, Nguyen-Van-Tam JS, English A, Falla TJ, Hawkey PM, Slack RC.

J Clin Microbiol. 2000 Jun;38(6):2311-6.

17.

Stabilization of Rhizobium symbiosis plasmids.

Falla TJ, Chopra I.

Microbiology. 1999 Mar;145 ( Pt 3):515-6. No abstract available.

PMID:
10217483
18.
19.

Antibiotics, peptidoglycan synthesis and genomics: the chlamydial anomaly revisited.

Chopra I, Storey C, Falla TJ, Pearce JH.

Microbiology. 1998 Oct;144 ( Pt 10):2673-8. Review. No abstract available.

PMID:
9802008
20.

Improved activity of a synthetic indolicidin analog.

Falla TJ, Hancock RE.

Antimicrob Agents Chemother. 1997 Apr;41(4):771-5.

21.

Mode of action of the antimicrobial peptide indolicidin.

Falla TJ, Karunaratne DN, Hancock RE.

J Biol Chem. 1996 Aug 9;271(32):19298-303.

22.

Antimicrobial peptides: broad-spectrum antibiotics from nature.

Hancock RE, Falla TJ.

Clin Microbiol Infect. 1996 Jun;1(4):226-229. No abstract available.

23.
24.

Characterization of capsular genes in Haemophilus influenzae isolates from H. influenzae type b vaccine recipients.

Falla TJ, Crook DW, Anderson EC, Ward JI, Santosham M, Eskola J, Moxon ER.

J Infect Dis. 1995 Apr;171(4):1075-6. No abstract available.

PMID:
7706799
25.

PCR for capsular typing of Haemophilus influenzae.

Falla TJ, Crook DW, Brophy LN, Maskell D, Kroll JS, Moxon ER.

J Clin Microbiol. 1994 Oct;32(10):2382-6.

26.

Population-based study of non-typable Haemophilus influenzae invasive disease in children and neonates.

Falla TJ, Dobson SR, Crook DW, Kraak WA, Nichols WW, Anderson EC, Jordens JZ, Slack MP, Mayon-White D, Moxon ER.

Lancet. 1993 Apr 3;341(8849):851-4.

PMID:
8096561
27.

Cross-reaction of spontaneous capsule-deficient Haemophilus influenzae type b mutants with type-specific antisera.

Falla TJ, Anderson EC, Chappell MM, Slack MP, Crook DW.

Eur J Clin Microbiol Infect Dis. 1993 Feb;12(2):147-8. No abstract available.

PMID:
8500485

Supplemental Content

Loading ...
Support Center